Q
Qiang Liu
Researcher at Tsinghua University
Publications - 836
Citations - 29296
Qiang Liu is an academic researcher from Tsinghua University. The author has contributed to research in topics: Medicine & Laser. The author has an hindex of 60, co-authored 652 publications receiving 20634 citations. Previous affiliations of Qiang Liu include Northeast Petroleum University & Guangdong University of Technology.
Papers
More filters
Journal ArticleDOI
Compact multi-channel surface plasmon resonance sensor for real-time multi-analyte biosensing.
TL;DR: This compact, cost-effective multi-channel SPR biosensor is adapted for point-of-care tests, which are important in healthcare and environmental monitoring and for biomolecular interaction analysis.
Journal ArticleDOI
Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer.
Di Huang,Xueman Chen,Xin Zeng,Liyan Lao,Jiaqian Li,Yue Xing,Yiwen Lu,Qian Ouyang,Jianing Chen,Linbin Yang,Fengxi Su,Herui Yao,Qiang Liu,Shicheng Su,Erwei Song +14 more
TL;DR: In this article, upregulation of regulator of G protein signaling (RGS)1 in helper TH1 cells and cytotoxic T lymphocytes (CTLs) was associated with shorter survival of patients with breast and lung cancer.
Journal ArticleDOI
Coordination tailoring of water-labile 3D MOFs to fabricate ultrathin 2D MOF nanosheets
TL;DR: 2D ultrathin MOF nanosheets with a two-fold interpenetrated architecture have been rapidly obtained from a 3D pillar-layered MOF, and they show distinguished fluorescence responses to different solvents.
Journal ArticleDOI
High-slope-efficiency 2.06 μm Ho: YLF laser in-band pumped by a fiber-coupled broadband diode.
TL;DR: The performance in both the CW and Q-switched regimes indicates that the current fiber-coupled diode in-band pumped Ho: YLF laser has great potential in certain conditions that require several watts of output power or several millijoules of short pulse energy.
Journal ArticleDOI
Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy
Chang Gong,Bodu Liu,Yandan Yao,Shaohua Qu,Wei Luo,Weige Tan,Qiang Liu,Herui Yao,Lee Zou,Fengxi Su,Erwei Song +10 more
TL;DR: This work shows that CTCs of breast cancer are more resistant to chemotherapy than PTCs because of potentiated DNA repair, and suggests that DNA damage checkpoint inhibitors may benefit the chemotherapy of Breast cancer patients by suppressing the chemoresistance of C TCs and reducing the risk of cancer metastasis.